Close Menu

The US Government Accountability Office recently released its findings from a sting conducted on several companies that sell direct-to-consumer genetic tests, finding that the results of such tests are often "of little or no practical use." But, writes Emily Singer in MIT's Technology Review, the most "shocking" findings come from a series of undercover phone calls made to 15 of these companies by GAO workers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.